Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus

The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is because of high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany’s economic condit...
André Will-Laudien | April 24, 2024 |

Find Out Why this Uranium Junior Mining Company Has a Distinctive Competitive Advantage

Skyharbour Resources (TSX.V: SYH | OTCQB: SYHBF) Jordan Trimble the CEO of Skyhabour Resources sits down with Maurice Jackson of Proven and Probable to discuss a number of catalyst’s that are emerging in the uranium ...
Maurice Jackson | April 3, 2020 |

This Uranium Explorer Set to Profit in Market Upswing

Skyharbour Resources (TSX.V: SYH | OTCQB: SYHBF ) has just released its most comprehensive interview. Proven and Probable has just conducted an exclusive interview with CEO Jordan Trimble. We address the value proposition of uranium, and most import...
Maurice Jackson | July 15, 2019 |

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News

Shares of migraine treatment research firm Alder BioPharmaceuticals opened 84% higher today after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion. Early this morning, clinical-stage biopharmaceutical company Alder BioPharmaceu...
Streetwise Reports | September 17, 2019 |

A Dual Threat Gold & Silver Opportunity in BC’s Prolific Cariboo Mining Region

When Stockhouse Editorial last caught up with Green River Gold Corp. (CCR) ( CSE.CCR , Forum ) and its CEO Perry Little last December , the company was, like so many others, adjusting to doing business in a COVID-19 world but at the same time keeping busy...
Dave Jackson | May 27, 2021 |

The Dual Threat Gold & Silver Opportunity that’s Rocking in the Cariboo

When we last just touched base via podcast about a year-and-a-half ago, Green River Gold Corp. (CCR) ( CSE.CCR , OTC: CCRRF , Forum ) had completed a very busy summer in the mining industry in British Columbia's Cariboo region. Fast-forward to today, and things contin...
Dave Jackson | December 10, 2021 |

The Brilliant Hidden Agenda Behind Trump’s Greenland Buyout

“ Build the wall! ” he chanted. And they laughed. Until he actually started building the wall. “ Cut corporate taxes! ” he campaigned. And they laughed. Until the Tax Cuts and Jobs Act of 2017. “Buy Greenland...
Marin Katusa | August 30, 2019 |

Gold Bugs: Pay Close Attention to This Data

Last Updated on Interest in gold and gold stocks has skyrocketed in the last 2 weeks. And for good reason. Let’s recap what we’ve just seen in short order… Explosive price gains – check . Massive changes in investor senti...
Marin Katusa | April 17, 2020 |

Alpine Immune Shares Soar 160% on Global Option and License Agreement with AbbVie

Shares of Alpine Immune Sciences set a new 52-week high after the company reported that it entered into an exclusive worldwide option and license agreement with AbbVie Inc. to develop and commercialize ALPN-101. Clinical-stage immunotherapy company Alpine Immune S...
Streetwise Reports | June 19, 2020 |

Mining play provides exploration update

The following is a transcription of the above video, and The Market Online has edited it for clarity . Geologica Resource Corp. (CSE:GRCM) is a dual-listed company in Canada on the CSE and in Germany on the Frankfurt Exchange. The company is engaged in the acquisit...
Brieanna McCutcheon | April 19, 2024 |
1 2 3 4 5 6